Sanvar vapreotide regulatory update

FDA's Gastrointestinal Drugs Advisory Committee will meet on May 19 to discuss an NDA from Debiopharm for Sanvar vapreotide to treat acute esophageal variceal bleeding. Last November, Debiopharm submi...